Elevated Prostate Health Index (phi) and Biopsy Reclassification During Active Surveillance of Prostate Cancer

The Prostate Health Index (phi) has been FDA approved for decision-making regarding prostate biopsy. Phi has additionally been shown to positively correlate with tumor volume, extraprostatic disease and higher Gleason grade tumors. Here we describe a case in which an elevated phi encouraged biopsy o...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Urol Case Rep
Main Authors: Andreas, Darian, Tosoian, Jeffrey J., Landis, Patricia, Wolf, Sacha, Glavaris, Stephanie, Lotan, Tamara L., Schaeffer, Edward M., Sokoll, Lori J., Ross, Ashley E.
Formato: Artigo
Idioma:Inglês
Publicado em: Elsevier 2016
Assuntos:
Oncology
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4909527/
https://ncbi.nlm.nih.gov/pubmed/27335798
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.eucr.2016.04.012
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados